November is a time of reflection and celebration as we honor Native American Heritage Month. This annual observance is dedicated to recognizing the rich cultures, traditions, and histories of indigenous Americans. The countless contributions of Native Americans are woven into the very fabric of our nation, shaping its identity in profound ways. At Cancer Research And […]
Honoring Native American Heritage Month Read More »
November is Lung Cancer Awareness Month. Lung cancer is the leading cause of cancer death in the United States, killing more people than breast, colon and prostate cancer combined. Yet it receives less federal research funding per patient than those cancers. This month Cancer Research And Biostatistics (CRAB) is raising awareness for lung cancer and
Lung Cancer Awareness Month Read More »
Cancer Research And Biostatistics statisticians traveled to Singapore earlier this month to attend the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee which was hosted alongside the annual IASLC 2023 World Conference on Lung Cancer. This renowned conference brings together lung cancer clinicians, researchers and scientists from around the world where the
Cancer Research And Biostatistics (CRAB) CEO, Antje Hoering, PhD, is in La Jolla, California, this week where she serves as faculty for the American Society of Hematology Clinical Research Training Institute (ASH CRTI). ASH CRTI is a unique training program for early career hematologists. It comprises a week-long workshop aimed at equipping hematologists with foundational
Antje Hoering Serves as Faculty at ASH CRTI Read More »
Friends of Cancer Research work on ctDNA focuses on collaboratively establishing evidence to support the use of ctDNA as an early endpoint. Cancer Research And Biostatistics (CRAB) serves as the independent analysis center for this project and as such we are responsible for all the analyses. CRAB is incredibly proud to be part of this
CRAB Collaborates with FoCR on ctDNA Work Read More »
Cancer Research And Biostatistics (CRAB) founder John Crowley, PhD and CRAB CEO, Antje Hoering, PhD, were invited by Taylor & Francis Group to serve as editors for the Fourth Edition of the Handbook of Statistics in Clinical Oncology. For this fourth edition, Megan Othus, PhD, from the Fred Hutch will join the editorial team. Many
CRAB Edits Fourth Edition of the Handbook of Statistics in Clinical Oncology Read More »
Cancer Research And Biostatistics (CRAB) is excited to be a part of the Pragmatica-Lung trial (S2302) which is set to be activated by 2/27/23. The S2302 Pragmatica-Lung trial is a phase 3 follow-up trial to Lung-MAP. S2302 is a new approach to clinical trials with the intent to streamline the existing model of clinical trials
Pragmatica-Lung Trial (S2302) Read More »
